Viewing Study NCT06400199



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06400199
Status: RECRUITING
Last Update Posted: 2024-05-06
First Post: 2023-11-01

Brief Title: Fertility Preservation for Transfeminine Adolescents Via Semen Cryopreservation or Testicular Sperm Extraction
Sponsor: Amsterdam UMC location VUmc
Organization: Amsterdam UMC location VUmc

Study Overview

Official Title: Succesfull Fertility Preservation for Transfeminine Adolescents Via Semen Cryopreservation or Testicular Sperm Extraction
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TESE
Brief Summary: The goal of this observational cohort study is to identify and predict parameters for successful testicular sperm extraction TESE procedures or semen cryopreservation more accurately and to evaluate the decision making process and the experience of postponing or temporarily discontinuing puberty suppression to undergo successful fertility preservation in transfeminine assigned male at birth adolescents The main questions it aims to answer are

What is the optimal timing for fertility preservation before the start or after temporarily discontinuing puberty suppression puberty suppression
How do transfeminine adolescents and their parents experience the decision making process of fertility preservation
how do transfeminine adolescents and their parents experienced postponing or temporarily discontinuing puberty suppression to undergo successful fertility preservation

Participants will be asked to use their medical data answer a questionnaire or participate in a online interview
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None